fairli
recent
customari
absenc
clinic
signific
infect
view
human
organ
isol
entiti
fact
healthi
human
bodi
alway
contain
larg
number
foreign
cell
virus
virgin
et
al
dethlefsen
et
al
relman
viral
particl
human
bodi
microbi
cell
ten
time
numer
eukaryot
human
cell
similarli
human
genom
encod
recogniz
human
protein
wherea
approxim
genom
retrotransposon
dna
transposon
viral
sequenc
humanassoci
microb
virus
often
found
extern
surfac
line
lumen
organ
gut
oralnas
caviti
particip
complex
commens
mutualist
relationship
human
host
dethlefsen
et
al
relman
therefor
advantag
attempt
erad
everi
viru
microbi
cell
bodi
respons
infect
new
medic
paradigm
emerg
ill
may
defin
disrupt
normal
healthi
microbiom
andor
virom
restor
state
elimin
nonhuman
organ
goal
medic
treatment
harrison
current
interest
human
microbiom
reflect
increas
accept
view
microbiota
per
se
seen
mere
invas
diseas
vector
fact
intrins
part
human
supraorgan
dethlefsen
et
al
classic
method
viral
isol
cultur
koch
postul
river
dictat
condit
viru
cultur
vitro
regard
caus
infecti
diseas
human
virus
usual
cultur
context
addit
cultur
success
small
fraction
virus
appropri
cultur
condit
determin
break
limit
view
virus
intrins
harm
requir
new
methodolog
enabl
us
character
entir
uncultur
viral
commun
cultureindepend
metagenom
approach
viral
commun
analysi
yield
broader
view
human
virom
metagenom
sequenc
reveal
wider
rang
bacteria
human
microbiom
culturebas
method
harri
et
al
roger
et
al
viral
metagenom
virom
total
genet
dna
rna
sequenc
deriv
viral
commun
mathemat
structur
commun
may
repres
graph
whose
function
form
lognorm
power
function
etc
reflect
rel
abund
distribut
member
even
distribut
fraction
contribut
genotyp
along
rich
total
number
genotyp
often
combin
denot
divers
commun
index
h
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
h
sumlimit
ri
ln
ri
end
document
sampl
rich
r
rel
abund
genotyp
viral
commun
tend
unevenli
distribut
small
number
speci
genotyp
domin
abund
fig
metagenom
greatli
facilit
recent
advanc
sequenc
technolog
pyrosequenc
life
scienc
well
technolog
eg
solexa
solid
enabl
routin
dna
sequenc
scale
bp
new
highthroughput
method
replac
tradit
clone
bacteria
mechan
separ
dna
molecul
mean
eg
empcr
dna
immobil
bead
requir
creation
minim
bias
dna
librari
better
reflect
viral
commun
sampl
present
origin
dna
sampl
must
often
amplifi
sequenc
increas
opportun
artifici
underrepresent
particular
sequenc
despit
limit
method
appear
avoid
problem
associ
convent
clone
subject
strong
sequenc
bia
unclon
sequenc
phenomenon
appear
particularli
pronounc
attempt
clone
viral
sequenc
microarray
well
remain
semiquantit
detect
method
imposs
simultan
optim
hybrid
thousand
individu
sequenc
tabl
approach
question
two
direct
estim
number
phage
expect
base
size
human
microbiom
typic
viral
phage
host
ratio
direct
count
virus
sampl
healthi
individu
human
bodi
compos
cell
savag
time
number
microbi
cell
associ
healthi
human
bodi
savag
observ
ratio
virallik
particl
per
microbi
cell
environment
rohwer
human
sampl
furlan
mean
could
expect
find
phage
bodi
possibl
compar
predict
result
recent
studi
data
tabl
direct
count
virus
use
epifluoresc
microscopi
data
indic
presenc
approxim
virus
bodi
wherev
microb
bacteria
archaea
present
virus
found
thu
human
bodi
region
high
microbi
level
particular
gut
also
highest
abund
virus
organ
system
mucu
membran
nasal
oral
caviti
vagina
harbor
smaller
signific
viral
commun
compar
environment
viral
commun
divers
human
virom
low
estim
viral
genotyp
typic
healthi
human
virom
contrast
kg
marin
sediment
contain
least
ten
thousand
perhap
million
viral
genotyp
humanassoci
virus
unevenli
distribut
bulk
virom
compos
hand
domin
speci
tabl
limit
data
avail
date
appear
diseas
state
correl
increas
divers
virom
willner
et
al
virus
phage
also
certain
eukaryot
virus
herpesvirus
anellovirus
papillomavirus
ubiquit
human
virom
tend
caus
problem
consid
abund
virgin
et
al
see
also
fig
commens
microb
ubiquit
healthi
human
bodi
dethlefsen
et
al
wilson
occupi
nich
skin
grice
et
al
distal
gut
gill
et
al
turnbaugh
et
al
vagina
hyman
et
al
result
virus
infect
microb
phage
numer
letarov
kulikov
found
gut
rey
et
al
nasopharynx
alland
et
al
oropharynx
willner
et
al
oral
caviti
hitch
et
al
blood
breitbart
rohwer
lung
secret
willner
et
al
phage
compris
far
major
human
virom
willner
et
al
expect
exert
influenc
human
microbi
commun
gill
et
al
hendrix
parallel
interact
observ
varieti
environment
sampl
letarov
kulikov
weinbauer
rodriguezmuel
et
al
breitbart
et
al
kill
specif
host
organ
phage
regul
absolut
rel
abund
microbi
speci
breitbart
et
al
genet
variat
host
therefor
favor
mean
escap
phage
predat
kunin
et
al
addit
phage
major
vehicl
dna
transfer
host
cell
horizont
gene
transfer
lytic
lysogen
pathway
littl
potenti
confer
new
phenotyp
increas
pathogen
breitbart
et
al
fit
sharon
et
al
wagner
waldor
host
analysi
phage
metagenom
thu
provid
inform
potenti
host
taxonomi
also
reveal
potenti
metabol
pathway
avail
microbi
commun
willner
et
al
sharon
et
al
box
show
core
phage
metagenom
found
human
lower
respiratori
tract
phage
type
present
five
normal
control
subject
five
cystic
fibrosi
patient
willner
et
al
fig
virus
capabl
infect
human
host
eukaryot
virus
obvious
present
diseas
individu
also
found
healthi
subject
virgin
et
al
willner
et
al
asymptomat
subject
abund
virus
far
lower
phage
healthi
human
bodi
willner
et
al
depend
area
bodi
examin
presenc
eukaryot
virus
due
either
transient
environment
exposur
access
region
eg
lung
chronic
infect
give
rise
recogniz
clinic
symptom
lack
symptom
might
reflect
lowlevel
viral
infect
success
suppress
immun
system
earli
stage
perhap
commens
viru
caus
appar
harm
virgin
et
al
stapleton
et
al
okamoto
antonsson
et
al
exampl
latter
torqu
teno
viru
ttv
origin
thought
associ
form
hepat
seem
like
ubiquit
benign
commens
viru
okamoto
instanc
true
mutual
context
yet
well
understood
suggest
coinfect
gb
viru
type
c
origin
term
hepat
g
viru
reduc
mortal
hivinfect
individu
stapleton
et
al
box
show
core
eukaryot
viral
metagenom
found
human
lower
respiratori
tract
virus
present
five
normal
control
subject
five
cystic
fibrosi
patient
willner
et
al
character
virus
persist
resid
time
bodi
degre
mutual
exhibit
fig
virus
compris
core
human
virom
rel
persist
never
clear
bodi
distinguish
pathogen
virus
caus
acut
shortliv
infect
howev
number
pathogen
virus
herpesvirus
may
persist
bodi
intracellular
form
caus
sporad
shed
viral
particl
still
virus
transient
common
member
human
virom
plant
virus
pmmv
taken
food
pass
directli
digest
tract
zhang
et
al
sar
coronaviru
discov
hybrid
nucleic
acid
array
virochip
contain
sequenc
repres
fulli
sequenc
virus
physic
remov
anneal
dna
array
pcr
amplifi
dna
use
primer
complementari
linker
ad
kistler
et
al
wang
et
al
chiu
et
al
prime
exampl
approach
clone
sequenc
sar
coronaviru
ksiazek
et
al
limit
method
succeed
virus
share
signific
homolog
previous
known
virus
simultan
optim
multipl
hybrid
array
may
imposs
sever
variat
randomli
prime
reversetranscript
pcr
rtpcr
amplif
rna
viral
sequenc
viral
rna
convert
cdna
use
primer
contain
random
octam
first
secondstrand
synthesi
follow
pcr
amplif
method
success
identifi
mani
rna
virus
human
sampl
exampl
found
victoria
et
al
nakamura
et
al
jone
et
al
method
may
limit
pcr
amplif
bia
highli
sensit
dna
viral
metagenom
includ
mani
phage
sequenc
purif
viral
particl
cscl
densiti
gradient
centrifug
dnase
treatment
dna
isol
random
amplif
phi
dna
polymeras
exampl
respiratori
tract
metagenom
mostli
phage
cf
noncf
subject
willner
et
al
oropharyng
metagenom
pool
sampl
healthi
individu
willner
et
al
limit
potenti
amplif
bia
polymeras
favor
small
circular
larg
linear
genom
method
prove
success
dna
rna
virus
due
untarget
natur
metagenom
often
unavoid
contamin
viral
nucleic
acid
larg
amount
human
dna
highthroughput
sequenc
essenti
date
life
scienc
gsflx
platform
forefront
technolog
particularli
long
sequenc
read
necessari
shotgun
sequenc
sequenc
technolog
current
experienc
unpreced
expans
howev
would
surpris
see
seri
signific
chang
sequenc
methodolog
near
futur
metagenom
character
taxonomi
also
cumul
metabol
potenti
encod
metagenom
meyer
et
al
case
viral
sequenc
data
deriv
lung
sputum
cf
patient
healthi
subject
diseas
state
individu
correl
strongli
metabol
potenti
viral
metagenom
taxonom
analysi
willner
et
al
mani
case
phage
commun
appear
carri
gene
complement
function
microbi
commun
particular
phage
often
seem
use
gene
protein
increas
shortterm
energi
output
host
cell
either
increas
viabil
lysogeni
boost
product
viral
particl
lytic
bacteria
cholera
depend
phage
infect
achiev
virul
recent
similarityindepend
method
develop
requir
databas
search
exampl
phacc
angli
et
al
use
contig
spectra
deriv
sequenc
data
infer
divers
genotyp
present
origin
sampl
method
enabl
comparison
one
metagenom
anoth
basi
rel
abund
share
sequenc
method
identifi
unknown
virus
help
character
sampl
defin
overal
complex
commun
method
involv
analysi
base
percent
gc
content
genom
rel
frequenc
variou
dinucleotid
combin
karlin
et
al
burg
et
al
karlin
willner
et
al
case
diagnost
particular
taxa
virus
purifi
human
environment
sampl
extract
dna
inevit
yield
larg
number
sequenc
usual
show
signific
similar
known
sequenc
fig
willner
et
al
jone
et
al
provid
adequ
precaut
taken
avoid
contamin
nonvir
nucleic
acid
suggest
larg
fraction
exist
viral
divers
remain
uncharacter
one
strength
untarget
approach
viral
metagenom
sequenc
obtain
understand
origin
signific
unknown
viral
sequenc
substanti
bioinformat
challeng
yet
solv
sequenc
similar
dna
known
organ
defin
blast
mcginni
madden
similar
search
algorithm
method
must
develop
purpos
exampl
genom
organ
pattern
largescal
arrang
open
read
frame
regulatori
element
promot
enhanc
origin
replic
may
signatur
would
identifi
sequenc
viral
origin
approach
would
like
requir
long
sequenc
even
complet
genom
success
accur
assess
normal
human
virom
provid
refer
point
detect
novel
virus
serv
background
emerg
pathogen
bioterror
agent
would
appear
human
popul
suitabl
screen
program
health
human
subject
judg
variat
true
commun
assumpt
nonhuman
entiti
present
analog
restor
disturb
ecosystem
knowledg
normal
viral
commun
assess
perturb
found
patient
may
enabl
physician
diagnos
disturb
microbiom
